Droplet Microfluidics-Enabled High-Throughput Screening for Protein Engineering

Abstract

Protein engineering—the process of developing useful or valuable proteins—has successfully created a wide range of proteins tailored to specific agricultural, industrial, and biomedical applications. Protein engineering may rely on rational techniques informed by structural models, phylogenic information, or computational methods or it may rely upon random techniques such as chemical mutation, DNA shuffling, error prone polymerase chain reaction (PCR), etc. The increasing capabilities of rational protein design coupled to the rapid production of large variant libraries have seriously challenged the capacity of traditional screening and selection techniques. Similarly, random approaches based on directed evolution, which relies on the Darwinian principles of mutation and selection to steer proteins toward desired traits, also requires the screening of very large libraries of mutants to be truly effective. For either rational or random approaches, the highest possible screening throughput facilitates efficient protein engineering strategies. In the last decade, high-throughput screening (HTS) for protein engineering has been leveraging the emerging technologies of droplet microfluidics. Droplet microfluidics, featuring controlled formation and manipulation of nano- to femtoliter droplets of one fluid phase in another, has presented a new paradigm for screening, providing increased throughput, reduced reagent volume, and scalability. We review here the recent droplet microfluidics-based HTS systems developed for protein engineering, particularly directed evolution. The current review can also serve as a tutorial guide for protein engineers and molecular biologists who need a droplet microfluidics-based HTS system for their specific applications but may not have prior knowledge about microfluidics. In the end, several challenges and opportunities are identified to motivate the continued innovation of microfluidics with implications for protein engineering.

Robotics for enzyme technology: innovations and technological perspectives

“…Droplet-based microfluidic devices have been developed and become essential tools for assaying many enzymes, as they display superior high-throughput capabilities with reduced assay volumes (Longwell et al 2017). In particular, droplet-based microfluidics has been effectively used to fabricate nano-to-picoliter-scale formats with controlled form and composition, based on an aqueous solution's emulsification immiscible non-polar solution-like oil (Weng and Spoonamore 2019). A significant advantage of dropletbased microfluidics is that droplets are compatible with various types of enzymes and assay formats.…”

Artificial intelligence in early drug discovery enabling precision medicine

“…Yet, to fully exploit the potential of machine learning models in drug discovery, we envision a AI-driven experimental design and a closedfeedback loop to continuously learn from newly generated results. Microfluidic drug development systems [210,211] and lab robotics will play a key component to reach the high degree of automation and throughput to realize such an AIdriven approach. In order to make an impact on drug discovery, these applications will need to demonstrate their ability to arrive at a potential drug candidate faster and more efficiently than in current pipelines.…”

Pushing the detection limits: strategies towards highly sensitive optical-based protein detection

“…In addition, assay miniaturization reduces the diffusion distance of the reagent molecules as opposed to the distances present in large volumes, resulting in higher antibody-antigen binding efficiency and shorter assay time [ 17 ]. Other advantages of miniaturized assays are reduced costs and lower levels of invasiveness, as less sample volumes need to be obtained [ 18 ].…”